Jack Slevin
Stock Analyst at Jefferies
(2.03)
# 2,502
Out of 5,182 analysts
6
Total ratings
60%
Success rate
6.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jack Slevin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Upgrades: Buy | $28 → $48 | $54.23 | -11.49% | 2 | May 7, 2026 | |
| ASTH Astrana Health | Maintains: Buy | $44 → $37 | $39.30 | -5.85% | 1 | Nov 25, 2025 | |
| MD Pediatrix Medical Group | Maintains: Buy | $14 → $18 | $23.51 | -23.44% | 2 | Nov 5, 2024 | |
| TOI The Oncology Institute | Assumes: Buy | $2.5 | $4.00 | -37.50% | 1 | Feb 26, 2024 |
agilon health
May 7, 2026
Upgrades: Buy
Price Target: $28 → $48
Current: $54.23
Upside: -11.49%
Astrana Health
Nov 25, 2025
Maintains: Buy
Price Target: $44 → $37
Current: $39.30
Upside: -5.85%
Pediatrix Medical Group
Nov 5, 2024
Maintains: Buy
Price Target: $14 → $18
Current: $23.51
Upside: -23.44%
The Oncology Institute
Feb 26, 2024
Assumes: Buy
Price Target: $2.5
Current: $4.00
Upside: -37.50%